PUBLIC NOTICE OF COUNTERFEITFLOWFLEX® COVID-19 ANTIGEN HOME TEST KITS
ACON Laboratories, Inc., has become aware that counterfeit versions of its FDA-authorized Flowflex® COVID-19 Antigen Home Tests in the 1 Test/ kit box configuration marked as Lot# COV2010030 and...
View ArticleTrade Shows 2023
ECRM Diabetes, Diagnostic & Clinical Session May 8-11, 2023 Green Valley Ranch Resort & Spa Henderson, Nevada AACC American Association for Clinical Chemistry July 25-27, 2023 Anaheim...
View ArticleSTATEMENT ON THE NEW OMICRON VARIANTS (BQ.1.1, BQ.1, XBB.1.5, XBB, and BF.7)
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants to ensure that the Flowflex® COVID-19 Antigen Home Test can detect them. The Omicron variant of concern...
View ArticleFlowflex COVID-19 Antigen Home Test New Shelf-life Extension
Since the launch of its Flowflex COVID-19 Antigen Home Test, ACON Laboratories, Inc. has continued testing for product stability to extend the shelf-life. These results have been shared with the FDA....
View ArticleSTATEMENT ON THE OMICRON EG.5 and FL.1.5.1 VARIANT
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants. According to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker, the Omicron variant...
View ArticleACON Laboratories, Inc. Announces the Launch of On Call® MultiPro
HbA1c, ACR and CRP Now Available in Europe and Latin America San Diego — August 30, 2023, ACON Laboratories, Inc. announced availability of the On Call® MultiPro System for point-of-care testing in...
View ArticleRecall Issued by the Philadelphia Department of Public Health for Counterfeit...
ACON Laboratories, Inc. is aware of the announcement by the Philadelphia Department of Public Health of a recall of certain at-home COVID-19 tests on September 9, 2023, and actively working with them...
View ArticleACON Receives FDA 510(k) Clearance for Flowflex® COVID-19 Test; Will be...
SAN DIEGO, CA, November 9, 2023 – ACON Laboratories, Inc. is proud to announce that the U.S. Food & Drug Administration (FDA) has granted 510(k) marketing clearance for the Flowflex® COVID-19...
View ArticleSTATEMENT ON THE OMICRON BA.2.86 and JN.1 VARIANTS
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants. According to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker, the Omicron variant...
View ArticleTrade Shows 2024
ECRM Diabetes, Diagnostics& Clinical Session May 8-11, 2024 Westin Kansas City at Crown Center Kansas City, Missouri ADLM (formerly AACC) Association for Diagnostics & Laboratory Medicine...
View Article